1683. Soundarya JSV, Uma Devi KR, Tripathy SP. Current trends in tuberculosis vaccine. Medical Journal Armed Forces India, 2019;75:18-24.
1684. Zayed H, Abdel Motal UM, Gopalakrishnan A, Ponnuraja C , Doss CGP, Rizk N, Shebl FM. R etinopathy of Type 1 diabetes in Arab countries: Systematic review and meta-analysis. Ophthalmic Research, 2019;61:125-136.
1685 Chadha VK, Anjinappa SM, Rade K, Baskaran D, Narang P, Kolappan C, Ahmed J, Praseeja P. Sensitivity and specificity of screening tools and smear microscopy in active tuberculosis case finding. Indian Journal of Tuberculosis, 2019;66(1):99-104.
1686. Ramachandran G, Hemanth Kumar AK, Kannan T, Sridhar R, Guha SK, Kadam D, Poorana Gangadevi N, Rajapandian T. Pharmacokinetics of rifabutin during atazanavir/ritonavir co-administration in HIV-infected TB patients. Indian Journal of Tuberculosis, 2019;66(1):129-133.
1687. Sarin R, Vohra V, Singla N, Thomas B, Rajendran K, Muniyandi M. Identifying costs contributing to catastrophic expenditure among TB patients registered under RNTCP in Delhi metro city in India. Indian Journal of Tuberculosis, 2019;66(1):150-157.
1688. Dolla CK , B askaran D , M uniyandi M , Padmapriyadarshini C , Hissar S , Mohan N , R ajendran K, Tripathy SP . Burden of pulmonary tuberculosis in modern prison: A cross sectional prevalence survey from south India. Indian Journal of Tuberculosis, 2019; 66(1):189-192.
1689. Mohan N, Sridhar R, Narendran G, Ramachandran G, Vinod Kumar V, Tripathy SP. Crusade for TB: Bringing treatment to masses at their doorsteps. Indian Journal of Medical Research, 2019;149(Supplement):89-93.
1690 Narayanaiah C, Sundaramurthi JC, Hemalatha B, Brahmaih A, Nesakumar M, Ashokkumar M, Vidya Vijayan KK, Tripathy SP, Swaminathan S, Vaniambadi SK, Ramanathan VD, Hanna LE. Mapping of neutralizing antibody epitopes on the envelope of viruses obtained from plasma samples exhibiting broad cross-clade neutralization potential against HIV-1. AIDS Research and Human Retroviruses, 2019; 35(2):169-184.
1691. Venugopal G, O'Regan NL, Babu S , Schumann RR, Srikantam A, Merle R, Hartmann S, Steinfelder S. Association of a PD-L2 gene polymorphism with chronic lymphatic filariasis in a south Indian Cohort. American Journal of Tropical Medicine and Hygiene, 2019;100(2):344-350.
1692. Silveira-Mattos PS, Narendran G, Akrami K, Fukutani KF, Anbalagan S, Nayak K, Sudha S, Subramani R, Vinhaes CL, Souza DO, Antonelli LR, Satagopan K, Porter BO, Sher A, Swaminathan S, Sereti I, Andrade BB. Differential expression of CXCR3 and CCR6 on CD4 + T-lymphocytes with distinct memory phenotypes characterizes tuberculosis-associated immune reconstitution inflammatory syndrome. Science Report, 201 9; 9(1):1502.
1693. Ramaiah A , Nayak S , Rakshit S , Manson AL , Abeel T , Sivakumar S, Sahoo PN , John AJUK , Sundaramurthi JC , Narayanan S, D'Souza G , von Hoegen P , Ottenhoff THM , Swaminathan S , Earl AM , Vyakarnam A . Evidence for highly variable, region-specific patterns of T-cell epitope mutations accumulating in Mycobacterium tuberculosis strains. Frontiers in Immunology, 2019;10:195.
1694. Srinivasan M , Shanmugam K , Kedike B , Narayanan S , Sivakumar S, Neelakantan H G . Trypethelone and phenalenone derivatives isolated from the mycobiont culture of Trypethelium eluteriae Spreng. and their anti-mycobacterial properties. Natural Product Research, 2019: 1-8.
1695. Rao VG , Bhat J , Yadav R , Sharma RK , Muniyandi M . Declining tuberculosis prevalence in Saharia, a particularly vulnerable tribal community in Central India: evidences for action. BMC Infectious Diseases, 2019;19(1):180.
1696. Makane VB, Krishna VS, Krishna EV, Shukla M, Mahizhaveni B, Misra S, Chopra S, Sriram D, Azger Dusthackeer VN , Rode HB. Synthesis and evaluation of a - aminoacyl amides as antitubercular agents effective on drug resistant tuberculosis. European Journal of Medicinal Chemistry, 2019;164:665–677.
1697. Pavan Kumar N, Kadar M, Bhootra Y, Nancy A, Viswanathan V, Shruthi BS, Sivakumar S, Natarajan M, Kornfeld H, Babu S . Elevated circulating levels of monocyte activation markers among tuberculosis patients with diabetes co-morbidity. Immunology, 2019; 156(3):249-258.
1698. Anuradha R, Saravanan M, Bhootra Y, Dolla CK, Nutman TB, Babu S . Co-existent helminth infection-mediated modulation of chemokine responses in latent tuberculosis. Journal of Immunology, 2019;202(5):1494-1500.
1699. Padmapriyadarsini C, Bhavani PK, Natrajan M, Ponnuraja C, Hemanth Kumar AK, Gomathy SN, Guleria R, Jawahar MS, Manjula S, Balganesh T, Swaminathan S. Evaluation of metformin in combination with rifampicin containing antituberculosis therapy in patients with new, smear-positive pulmonary tuberculosis (METRIF): study protocol for a randomised clinical trial. BMJ Open . 2019;9(3):e024363.
1700. Sivakumar S, Narender K, Dina N, Mohan N, Tripathy SP, Peacock SJ, Swaminathan S, Uma Devi R. Genome sequencing of polydrug-, multidrug-, and extensively drug-resistant Mycobacterium tuberculosis strains from south India. Microbiology Resource Announcements, 2019;8(12).
1701. Sivasankaran MP, Sathyamurthy P, Kannan T, Goyal R, Singla N, Mukherjee J, Chatrath S, Bergin P, T Kopycinski J, Gilmour J, Kumar S, Muthu M, Sudha S, Swaminathan S, Tripathy SP, Luke HE. Induction and maintenance of bi-functional (IFN-? + IL-2 + and IL-2 + TNF-a + ) T cell responses by DNA prime MVA boosted subtype C prophylactic vaccine tested in a Phase I trial in India. PLoS One, 2019;14(3):e0213911.
1702. Gokul Raj K, Saravanan M, Sridhar R, Baskaran D, Babu S . Helminth mediated modulation of the systemic and mycobacterial antigen - stimulated cytokine profiles in extra-pulmonary tuberculosis. PLoS Neglected Tropical Diseases, 2019;13(3): e0007265.
1703. Makane VB, Krishna VS, Krishna EV, Shukla M, Mahizhaveni B, Misra S, Chopra S, Sriram D, Azger Dusthackeer VN, Rode HB. Novel 1,3,4-oxadiazoles as antitubercular agents with limited activity against drug-resistant tuberculosis. Future Medicinal Chemistry, 2019;11(6):499-510.
1704. Saranathan R, Padmapriyadarsini C, Gomathi NS, Bhavani PK, Silambuchelvi K, Bency J, Narendran G, Hanna LE . Pulmonary Mycobacterium kyorinense disease: A case report and review of literature. Indian Journal of Medical Microbiology, 2019;37(1):127-131.
1705. Adams KN, Verma AK, Radha G, Harresh A, Dinesh Kumar S, Tripathy S, Uma Devi R , Sherman DR, Urdahl KB, Lalitha R, Hernandez RE. Diverse clinical isolates of Mycobacterium tuberculosis develop macrophage-induced rifampin tolerance. Journal of Infectious Diseases, 2019;219(10):1554-1558.
1706. Ponnuraja C, Valarmathi S, Dayal PL, Prasanth KB, Masthan KMK. Multi-state models for the time to event post-transplantation cancer data: A competing risks approach. Indian Journal of Public Health Research and Development, 2019; 10(4):283-292.
1707. Karikalan N, Das B. Tuberculosis and social networks: a narrative review on how social network data and metrics help explain tuberculosis transmission. Current Science, 2019;116(7):1068-1080.
1708. M uniyandi M, Rajeswari R. N o families affected by tuberculosis to face catastrophic costs by 2020: India's new strategic plan to eliminate tuberculosis. Indian Journal of Tuberculosis, 2019 ; 66(2):219-221.
1709. Gupte AN, Sriram S, Paradkar M, Danasekaran K, Shivakumar SVBY, Kannan T, Dolla C , Gomathy S, Pradhan N, Kohli R, John S, Raskar S, Jain D, Momin A, Balaji S, Gaikwad A, Lokhande R, Suryavanshi N, Gupte N, Salvi S, Murali L, Checkley W, Golub JE, Bollinger R, Padmapriyadarsini C, Mave V, Gupta A. Respiratory health status is associated with treatment outcomes in pulmonary tuberculosis. I nternational Journal of Tuberculosis and Lung Disease, 2019;23(4):450-457.
1710. Sivanantham A, Pattarayan D, Ramalingam B, Kar A, Mahapatra SK, Thimmulappa RK, Palanichamy R, Rajasekaran S. Tannic acid protects against experimental acute lung injury through downregulation of TLR4 and MAPK. Journal of Cellular Physiology, 2019;234(5):6463-6476.
1711. Hassan S, Sudhakar V, Nancy Mary MB, Babu R, Doble M, Dadar M, Hanna LE . Computational approach identifies protein off-targets for Isoniazid-NAD adduct: hypothesizing a possible drug resistance mechanism in Mycobacterium tuberculosis . Journal of Biomolecular Structure and Dynamics, 2019;16:1-14.
1712. Oliveira-de-Souza D, Vinhaes CL, Arriaga MB, Pavan Kumar N, Cubillos-Angulo JM, Shi R, Wei W, Yuan X, Zhang G, Cai Y, Barry CE III, Via LE, Sher A, Babu S , Mayer-Barber KD, Nakaya HI, Fukutani KF, Andrade BB. Molecular degree of perturbation of plasma inflammatory markers associated with tuberculosis reveals distinct disease profiles between Indian and Chinese populations. Science Report, 2019;29;9(1):8002.
1713. Gokul Raj K, Kadar M, Sridhar R, Baskaran D, Babu S . Enhanced mycobacterial antigen-induced pro-inflammatory cytokine production in lymph node tuberculosis. American Journal of Tropical Medicine and Hygiene, 2019;100(6):1401-1406.
1714. Daskapan A, Idrus LR, Postma MJ, Wilffert B, Kosterink JGW, Stienstra Y, Touw DJ, Andersen AB, Bekker A, Denti P, Hemanth Kumar AK, Jeremiah K, Kwara A, McIlleron H, Meintjes G, van Oosterhout JJ, Ramachandran G, Rockwood N, Wilkinson RJ, van der Werf TS, Alffenaar JC. A systematic review on the effect of HIV infection on the pharmacokinetics of first-line tuberculosis drugs. Clinical Pharmacokinetics , 2019, 58(6): 747–766.
1715. Narendran G , Oliveira-de-Souza D , Vinhaes CL , Akrami K , Fukutani KF , Banu K , Padmapriyadarsini C, Ravichandran N , Sereti I , Swaminathan S , Andrade BB . Multifocal tuberculosis-associated immune reconstitution inflammatory syndrome - a case report of a complicated scenario. BMC Infectious Diseases, 2019;19(1):529.
1716. Ramakrishnan K, Uma A, Senathipathy R, Vijayaraj S, Thirumalaikolundu-subramanian P, Rathinasabapati R, Mondal R. Pneumocystis carinii pneumonia in HIV infected patients from south India. International Journal of Current Research, 2019;11(6):4525-4527.
1717 Ramakrishnan K, Uma A, Rathinasabapati R, Thiyagarajan V, Vijayaraj S, Thirumalaikolundu Subramanian P, Senathipathy R, Mondal R. Immunoglobuling (IGG) status in pulmonary and extra opuylmonary tuberculosis. International Journal of Current Research, 2019;11(6):4560-4562.
1718. Swathirajan CR, Nandagopal P, Vignesh R, Srikrishnan AK, Goyal R, Qureshi H, Saravanan S, Solomon SS, Hanna LE , Sivasankaran MP, Singla N, Mukherjee J, Chatrath S, Kopycinski J, Murugavel KG. Association of circulatory Tfh-like cells with neutralizing antibody responses among chronic HIV-1 subtype C infected long- term nonprogressors and progressors. Pathogens and Disease, 2019;77(4).
1719. Lee DJ, Kumarasamy N, Resch SC, Gomathi NS, Mayer KH, Tripathy S, Paltiel AD, Freedberg KA, Reddy KP . Rapid, point-of-care diagnosis of tuberculosis with novel Truenat assay: Cost-effectiveness analysis for India's public sector. PLoS One, 2019;14(7):e0218890.
1720. Mave V , P admapriyadarsini C, Chavan A , Shivakumar SVBY , K avitha D, Paradkar M , Kannan T, Kinikar A , Murali L , Gaikwad S , Hanna LE , Kulkarni V , Sathyamoorthy P, Suryavanshi N , Thomas B , Kohli R , Gomathi NS, Pradhan N , Bhanu B , Kagal A , Golub J , Gandhi N , Gupte A , Gupte N , Swaminathan S , Gupta A , for the CTRIUMPH RePORT India study team . Infection free "resisters" among household contacts of adult pulmonary tuberculosis. PLoS One, 2019;14(7):e0218034.
1721. Munir A , Kumar N, Ramalingam SB, Tamilzhalagan S, Sivakumar S, Natarajan PL, Dina N, Padmapriyadarsini C, Natrajan M, Tripathy S, Uma Devi R, Peacock SJ, Parkhill J, Blundell TL, Malhotra S . Identification and characterization of genetic determinants of isoniazid and rifampicin resistance in Mycobacterium tuberculosis in southern India. Scientific Rep orts, 2019;9(1):10283:1-13.
1722. Pavan Kumar N, Fukutani KF, Shruthi BS, Alves T, Silveira-Mattos PS, Rocha MS, West K, Natarajan M, Viswanathan V, Babu S , Andrade BB, Kornfeld H. Persistent inflammation during anti-tuberculosis treatment with diabetes comorbidity. eLife, 2019;8: e46477-1-19.
1723. Pavan Kumar N, Kadar M, Banurekha VV, Dina N, Babu S. Plasma proinflammatory cytokines are markers of disease severity and bacterial burden in pulmonary tuberculosis. Open Forum Infect Diseases, 2019; 6(7):ofz257.
1724. Ramachandran G. Pharmacokinetics of second-line anti-tubercular drugs. Indian Journal of Pediatrics, 2019; 86(8):714-716.
1725. Manohar N, Hemalatha H, Narayanaiah C, Ramesh K, Kailasam N, Sathyamoorthy P, Murugesan S, Tripathy SP, Hanna LE . Transmitted HIV-1 drug resistance in a treatment-naïve cohort of recently infected individuals from Chennai, India. AIDS Research and Human Retroviruses. 2019; 35(8):775-779.
1726 Aralaguppe SG , Ambikan AT , Ashokkumar M , Kumar MM , Hanna LE , Amogne W , Sönnerborg A , Neogi U . MiDRM pol : A high-throughput multiplexed amplicon sequencing workflow to quantify HIV-1 drug resistance mutations against protease, reverse transcriptase, and integrase inhibitors. Viruses, 2019;11(9).
1727. Radha Bai Prabhu T, Pandiyan N, Sujatha N, Jawahar MS . Significance of isolating non-tuberculous mycobacterial organisms in infertile women with tubal disease: an observational study. BJOG ,2019;126 Suppl 4:66-71.
1728. Hemalatha B, Ambikan AT, Gabriel EE, Akusjärvi SS, Natarajan PL, Sundaraj V, Mupanni NR, Sperk M, Narayanaiah C, Sridhar R, Tripathy SP, Nowak P, Hanna LE , Neogi U. Systemic inflammation and the increased risk of inflamm-aging and age-associated diseases in people living with HIV on long term suppressive antiretroviral therapy. Frontiers in Immunology, 2019; 10:1965.
1729. Pavan Kumar N, Kadar M, Nancy A, Viswanathan V, Shruthi BS, Sivakumar S, Natarajan M, Kornfeld H, Babu S . Heterogeneity in the cytokine profile of tuberculosis - diabetes co-morbidity. Cytokine, 2019;125:154824 .
1730. Anuradha R, Saravanan M, Bhootra Y, Dolla C, Kannan T, Nutman TB, Babu S . Metabolic consequences of concomitant Strongyloides stercoralis infection in Type 2 diabetes mellitus. Clinical Infectious Diseases , 69(4):697–704.
1731. Devaleenal D B, Grace GA , Natrajan M . Tuberculous meningitis in children: Clinical management & outcome. Indian Journal of Medical Research, 2019; 150(2):117-130.
1732. Hemalatha B, Sperk M, Ambikan AT, Rachel G, Viswanathan VK, Tripathy SP, Nowak P, Hanna LE , Neogi U. Plasma metabolic signature and abnormalities in HIV-infected individuals on long-term successful antiretroviral therapy. Metabolites, 2019;9(10).
1733. Gokul Raj K, Pavan Kumar N, Kadar M, Sridhar R, Baskaran D, Babu S. Diminished type 1 and type 17 cytokine expressing - Natural killer cell frequencies in tuberculous lymphadenitis. Tuberculosis, 2019, 118:101856
1734. Refaya AK, Kumar N, Raj D, Veerasamy M, Balaji S, Sivakumar S, Rajendran A, Tripathy SP, Swaminathan S, Peacock SJ, Kannan P. Whole-Genome sequencing of a Mycobacterium orygis strain isolated from Cattle in Chennai, India. Microbiology Resource Announcements, 2019;8(40).
1735. Dolla CK, Padmapriyadarsini C , Kannan T, Lokhande R, Kinikar A, Paradkar M, Shrinivas BM, Lakshmi M, Gupte A, Gaikwad S, Sriram S, Padmanaban Y, Sathyamurthy P, Pradhan N, Kulkarni V, Shivakumar SVBY, Prithivi M, Kagal A, Karthavarayan BT, Suryavanshi N, Gupte N, Kumaran P, Mave V, Gupta A. Age- specific prevalence of TB infection among household contacts of pulmonary TB: Is it time for TB preventive therapy? Transactions of the Royal Society of Tropical Medicine and Hygiene ; 2019;113(10):632-640.
1736. Pavan Kumar N, Kadar M, Nancy A, Viswanathan V, Shruthi BS, Sivakumar S, Syed H, Kornfeld H, Babu S . Plasma eicosanoid levels in tuberculosis and tuberculosis-diabetes co-morbidity are associated with lung pathology and bacterial burden. Frontiers in Cellular and Infection Microbiology, 2019;9:335.
1737. Albuquerque VVS, Pavan Kumar N, Fukutani KF, Vasconcelos B, Arriaga MB, Silveira-Mattos PS, Babu S, Andrade BB. Plasma levels of C-reactive protein, matrix metalloproteinase-7 and lipopolysaccharide-binding protein distinguish active pulmonary or extrapulmonary tuberculosis from uninfected controls in children. Cytokine, 2019;123:154773.
1738. Subbaraman R, Thomas BE , Senthil S, Chandra S, Jayabal L, Lincy S, Raja AL, McFall A, Solomon SS, Mayer KH, Swaminathan S. Tuberculosis patients in an Indian mega-city: Where do they live and where are they diagnosed? Erratum in: PLoS One. 2019 Oct 30;14(10):e0224808 .
1739. Thomas BE , Thiruvengadam K, S R, Kadam D, Ovung S, Sivakumar S, Bala Yogendra Shivakumar SV, Paradkar M, Gupte N, Suryavanshi N, Dolla CK, Gupte AN, Kohli R, Pradhan N, Sivaramakrishnan GN, Gaikwad S, Kagal A, Dhanasekaran K, Deluca A, Golub JE, Mave V, Chandrasekaran P, Gupta A; CTRIUMPH-RePORT India Study. Smoking, alcohol use disorder and tuberculosis treatment outcomes: A dual co- morbidity burden that cannot be ignored. PLoS One , July 2019;14(7):e0220507. Erratum in: PLoS One, 2019 Nov 1;14(11):e0224914.
1740. Anuradha R, Saravanan M, Dolla C, Nutman TB, Babu S . Cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4)- and programmed death 1 (PD-1)- mediated regulation of monofunctional and dual functional CD4 + and CD8 + T-cell responses in a chronic helminth infection. Infection and Immunity, 2019;87(12).
1741. Sivanantham A, Pattarayan D, Rajasekar N, Kannan A, Loganathan L, Ramalingam B, Mahapatra SK, Palanichamy R, Muthusamy K, Rajasekaran S. Tannic acid prevents macrophage-induced pro-fibrotic response in lung epithelial cells via suppressing TLR4-mediated macrophage polarization. Inflammation Research, 2019;68(12):1011-1024.
1742. Azger D, Magizhaveni B, Govindarajan S, Shanmuga Priya, Christy RN, Ebenezer RS, Angayarkanni B, Mondal RK, Kannan T, Hemanth Kumar AK, Ramachandran G, Selvakumar S. Differential culturability of Mycobacterium tuberculosis in culture-negative sputum of patients with pulmonary tuberculosis and in a simulated model of dormancy. Frontiers in Microbiology, 2019;10:2381.
1743. Yuvaraj C, Venkatesan P, Ramalingam B, Tripathy SP, Swaminathan S, Uma Devi R. In vitro interaction profiles of the new antitubercular drugs bedaquiline and delamanid with moxifloxacin against clinical Mycobacterium tuberculosis isolates. Journal of Global Antimicrobial Resistance, 2019;19:348-353.
1744. Bhat J, Yadav R, Sharma RK, Muniyandi M , Rao VG. Tuberculosis elimination in India's Saharia group. Lancet Global Health , 2019;7(12):e1618. ((no abstract)